Home › Funds › TUDOR INVESTMENT CORP ET AL › MRNA

TUDOR INVESTMENT CORP ET AL position in MRNA

MODERNA INC · Health Care

TUDOR INVESTMENT CORP ET AL reported holding 265,600 shares of MRNA (MODERNA INC) in its Q3 2026 13F filing — a position valued at US$51.1M, representing 0.39% of its reported portfolio and ranking #37 among its reported holdings. TUDOR INVESTMENT CORP ET AL has disclosed MRNA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)265.60K sh
Reported value held$51.15M
Portfolio Weight0.39%
First reportedQ3 2023
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How TUDOR INVESTMENT CORP ET AL's MRNA position evolved

TUDOR INVESTMENT CORP ET AL first disclosed a stake in MRNA in Q3 2023 at 7,600 shares (US$785K). The position peaked in Q3 2026 at 265,600 shares, worth US$51.1M. Across 13 filings, TUDOR INVESTMENT CORP ET AL increased the stake 6 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 265,600 shares valued at US$51.1M — an increase of 247,400 shares quarter over quarter.. Notable position changes include a 559% increase in Q4 2023 (shares rose 7% over the following quarter), a 158% increase in Q2 2024 (shares fell 44% over the following quarter), a 1359% increase in Q3 2026 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 7.60K $785.00K New
Q4 2023 50.10K $4.98M Add
Q1 2024 48.20K $5.14M Reduce
Q2 2024 124.33K $14.76M Add
Q3 2024 153.10K $10.23M Add
Q4 2024 348.80K $14.50M Add
Q1 2025 270.20K $7.66M Reduce
Q2 2025 535.66K $14.78M Add
Q3 2025 344.55K $8.90M Reduce
Q4 2025 96.21K $2.84M Reduce
Q1 2026 78.70K $4.00M Reduce
Q2 2026 18.20K $1.27M Reduce
Q3 2026 265.60K $51.15M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRNA and 13F data

MRNA (MODERNA INC) is a Health Care company. 47 other funds we track also report a position in MRNA — the largest reported positions include Fidelity Management & Research (FMR) (US$11.35B), Capital World Investors (US$4.36B), Baillie Gifford & Co (US$2.20B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRNA

All MRNA fund holders →

FAQ

How long has TUDOR INVESTMENT CORP ET AL held MRNA?

TUDOR INVESTMENT CORP ET AL has disclosed MRNA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is TUDOR INVESTMENT CORP ET AL's current position in MRNA?

As of Q3 2026, TUDOR INVESTMENT CORP ET AL holds 265.60K shares of MRNA (MODERNA INC), valued at $51.15M, representing 0.39% of its reported portfolio and ranking #37.

Has TUDOR INVESTMENT CORP ET AL been buying or selling MRNA?

In the latest 13F filing (Q3 2026), TUDOR INVESTMENT CORP ET AL increased its position in MRNA. The position peaked in Q3 2026 at 265.60K shares.

Which other funds hold MRNA?

Other major institutional holders of MRNA include Fidelity Management & Research (FMR), Capital World Investors, Baillie Gifford & Co, among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.